Savino Benedetta, Borroni Elena Monica, Torres Nina Machado, Proost Paul, Struyf Sofie, Mortier Anneleen, Mantovani Alberto, Locati Massimo, Bonecchi Raffaella
Department of Translational Medicine, University of Milan, 20089 Milan, Italy.
J Biol Chem. 2009 Sep 18;284(38):26207-15. doi: 10.1074/jbc.M109.029249. Epub 2009 Jul 24.
The chemokine decoy receptor D6 controls inflammatory responses by selective recognition and degradation of most CCR1 to CCR5 agonistic ligands. CCL14 is a homeostatic chemokine present at high concentrations in the serum with a weak agonist activity on CCR1. Under inflammatory conditions, plasmin and UPA-mediated truncation of 8 amino acids generates the potent CCR1/CCR3/CCR5 isoform CCL14(9-74), which is further processed and inactivated by dipeptidyl peptidase IV/CD26 that generates CCL14(11-74). Here we report that D6 efficiently binds both CCL14 and its truncated isoforms. Like other D6 ligands, the biologically active CCL14(9-74) induces adaptive up-regulation of D6 expression on the cell membrane and is rapidly and efficiently degraded. In contrast, the D6-mediated degradation of the biologically inactive isoforms CCL14(1-74) and CCL14(11-74) is very inefficient. Thus, D6 cooperates with CD26 in the negative regulation of CCL14 by the selective degradation of its biologically active isoform. Analysis of a panel of CC chemokines and their truncated isoforms revealed that D6-mediated chemokine degradation does not correlate with binding affinity. Conversely, degradation efficiency is positively correlated with D6 adaptive up-regulation. Sequence analysis indicated that a proline residue in position 2 of D6 ligands is dispensable for binding but crucial for D6 adaptive up-regulation and efficient degradation.
趋化因子诱饵受体D6通过选择性识别和降解大多数CCR1至CCR5激动剂配体来控制炎症反应。CCL14是一种稳态趋化因子,在血清中浓度较高,对CCR1具有弱激动剂活性。在炎症条件下,纤溶酶和尿激酶型纤溶酶原激活剂介导的8个氨基酸的截短产生了强效的CCR1/CCR3/CCR5同种型CCL14(9-74),其进一步被二肽基肽酶IV/CD26加工并失活,生成CCL14(11-74)。在此我们报告,D6能有效结合CCL14及其截短的同种型。与其他D6配体一样,具有生物活性的CCL14(9-74)诱导细胞膜上D6表达的适应性上调,并迅速且有效地被降解。相比之下,D6介导的无生物活性同种型CCL14(1-74)和CCL14(11-74)的降解效率非常低。因此,D6通过选择性降解其生物活性同种型与CD26协同对CCL14进行负调控。对一组CC趋化因子及其截短同种型的分析表明,D6介导的趋化因子降解与结合亲和力无关。相反,降解效率与D6适应性上调呈正相关。序列分析表明,D6配体第2位的脯氨酸残基对于结合并非必需,但对于D6适应性上调和有效降解至关重要。